These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 35682754)
21. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux. Xuan F; Jian J Int J Mol Med; 2016 Jul; 38(1):328-36. PubMed ID: 27246989 [TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin 3-gallate: From green tea to cancer therapeutics. Alam M; Ali S; Ashraf GM; Bilgrami AL; Yadav DK; Hassan MI Food Chem; 2022 Jun; 379():132135. PubMed ID: 35063850 [TBL] [Abstract][Full Text] [Related]
23. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer. Wang J; Man GCW; Chan TH; Kwong J; Wang CC Cancer Lett; 2018 Jan; 412():10-20. PubMed ID: 29024813 [TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Van Aller GS; Carson JD; Tang W; Peng H; Zhao L; Copeland RA; Tummino PJ; Luo L Biochem Biophys Res Commun; 2011 Mar; 406(2):194-9. PubMed ID: 21300025 [TBL] [Abstract][Full Text] [Related]
25. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Bigelow RL; Cardelli JA Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979 [TBL] [Abstract][Full Text] [Related]
26. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Almatroodi SA; Almatroudi A; Khan AA; Alhumaydhi FA; Alsahli MA; Rahmani AH Molecules; 2020 Jul; 25(14):. PubMed ID: 32660101 [TBL] [Abstract][Full Text] [Related]
27. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Thangapazham RL; Passi N; Maheshwari RK Cancer Biol Ther; 2007 Dec; 6(12):1938-43. PubMed ID: 18059161 [TBL] [Abstract][Full Text] [Related]
28. Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer. Hung SW; Li Y; Chen X; Chu KO; Zhao Y; Liu Y; Guo X; Man GC; Wang CC Front Pharmacol; 2022; 13():906746. PubMed ID: 35860020 [TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling. Singh T; Katiyar SK Toxicol Appl Pharmacol; 2013 Dec; 273(2):418-24. PubMed ID: 24096034 [TBL] [Abstract][Full Text] [Related]
30. EGCG and ECG induce apoptosis and decrease autophagy via the AMPK/mTOR and PI3K/AKT/mTOR pathway in human melanoma cells. DU BX; Lin P; Lin J Chin J Nat Med; 2022 Apr; 20(4):290-300. PubMed ID: 35487599 [TBL] [Abstract][Full Text] [Related]
31. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656 [TBL] [Abstract][Full Text] [Related]
32. A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Qin J; Xie LP; Zheng XY; Wang YB; Bai Y; Shen HF; Li LC; Dahiya R Biochem Biophys Res Commun; 2007 Mar; 354(4):852-7. PubMed ID: 17266926 [TBL] [Abstract][Full Text] [Related]
33. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466 [TBL] [Abstract][Full Text] [Related]
34. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate. Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753 [TBL] [Abstract][Full Text] [Related]
35. Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes. Kim SN; Kwon HJ; Akindehin S; Jeong HW; Lee YH Nutrients; 2017 Jun; 9(7):. PubMed ID: 28665330 [TBL] [Abstract][Full Text] [Related]
36. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Yamauchi R; Sasaki K; Yoshida K Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223 [TBL] [Abstract][Full Text] [Related]
37. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757 [TBL] [Abstract][Full Text] [Related]
38. A new epigallocatechin gallate derivative isolated from Anhua dark tea sensitizes the chemosensitivity of gefitinib via the suppression of PI3K/mTOR and epithelial-mesenchymal transition. Liu J; Zhong T; Yi P; Fan C; Zhang Z; Liang G; Xu Y; Fan Y Fitoterapia; 2020 Jun; 143():104590. PubMed ID: 32272164 [TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells. Tsai CY; Chen CY; Chiou YH; Shyu HW; Lin KH; Chou MC; Huang MH; Wang YF Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267216 [TBL] [Abstract][Full Text] [Related]
40. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells. Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P Gene; 2021 Aug; 794():145774. PubMed ID: 34126197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]